Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease

The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severi...

Full description

Saved in:
Bibliographic Details
Published inClinical and molecular hepatology Vol. 19; no. 2; pp. 120 - 130
Main Authors Kim, Young Seok, Jung, Eun Sun, Hur, Wonhee, Bae, Si Hyun, Choi, Jong Young, Song, Myeong Jun, Kim, Chang Wook, Jo, Se Hyun, Lee, Chang Don, Lee, Young Sok, Choi, Sang Wook, Yang, Jin Mo, Jang, Jeong Won, Kim, Sang Gyune, Jung, Seung Won, Kim, Hee Kyung, Chae, Hee Bok, Yoon, Seung Kew
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Association for the Study of the Liver 01.06.2013
The Korean Association for the Study of the Liver
대한간학회
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH. One hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating centers across Korea. According to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4, none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAS components such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4-85.1), and 57.1% (95% CI 42.2-70.9), respectively, for the diagnosis of NASH. Serum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction.
AbstractList Background/AimsThe aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH.MethodsOne hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating centers across Korea.ResultsAccording to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4, none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAS components such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4-85.1), and 57.1% (95% CI 42.2-70.9), respectively, for the diagnosis of NASH.ConclusionsSerum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction.
Background/Aims: The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH. Methods: One hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD;males, 67.6%) were prospectively enrolled from 10 participating centers across Korea. Results: According to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4,none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAShecomponents such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4–85.1), and 57.1% (95% CI 42.2–70.9), respectively, for the diagnosis of NASH. Conclusions: Serum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction. (Clin Mol Hepatol 2013;19:120-130) KCI Citation Count: 3
The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH.BACKGROUND/AIMSThe aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH.One hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating centers across Korea.METHODSOne hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating centers across Korea.According to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4, none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAS components such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4-85.1), and 57.1% (95% CI 42.2-70.9), respectively, for the diagnosis of NASH.RESULTSAccording to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4, none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAS components such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4-85.1), and 57.1% (95% CI 42.2-70.9), respectively, for the diagnosis of NASH.Serum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction.CONCLUSIONSSerum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction.
The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH. One hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating centers across Korea. According to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4, none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAS components such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4-85.1), and 57.1% (95% CI 42.2-70.9), respectively, for the diagnosis of NASH. Serum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction.
Author Song, Myeong Jun
Kim, Sang Gyune
Jang, Jeong Won
Jung, Seung Won
Jung, Eun Sun
Chae, Hee Bok
Bae, Si Hyun
Lee, Chang Don
Lee, Young Sok
Yoon, Seung Kew
Choi, Sang Wook
Yang, Jin Mo
Hur, Wonhee
Kim, Young Seok
Kim, Hee Kyung
Kim, Chang Wook
Choi, Jong Young
Jo, Se Hyun
AuthorAffiliation 1 Department of Internal Medicine, Soon Chun Hyang University Hospital Bucheon, Soon Chun Hyang University College of Medicine, Bucheon, Korea
6 Department of Internal Medicine, The Catholic University of Korea Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
4 Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
8 Department of Internal Medicine, The Catholic University of Korea St. Paul's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
7 Department of Internal Medicine, The Catholic University of Korea Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Bucheon, Korea
5 Department of Internal Medicine, The Catholic University of Korea Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea
12 Department of Pathology, Soon Chun Hyang U
AuthorAffiliation_xml – name: 1 Department of Internal Medicine, Soon Chun Hyang University Hospital Bucheon, Soon Chun Hyang University College of Medicine, Bucheon, Korea
– name: 9 Department of Internal Medicine, The Catholic University of Korea St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea
– name: 10 Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Incheon, Korea
– name: 6 Department of Internal Medicine, The Catholic University of Korea Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– name: 13 Department of Internal Medicine, Chungbuk National University, College of Medicine, Cheongju, Korea
– name: 7 Department of Internal Medicine, The Catholic University of Korea Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Bucheon, Korea
– name: 11 Department of Internal Medicine, Soon Chun Hyang University Hospital Seoul, Soon Chun Hyang University College of Medicine, Seoul, Korea
– name: 2 Department of Pathology, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– name: 3 The Catholic University of Korea Liver Research Center & WHO Collaborating Center of Viral Hepatitis, The Catholic University of Korea College of Medicine, Seoul, Korea
– name: 12 Department of Pathology, Soon Chun Hyang University Hospital Bucheon, Soon Chun Hyang University College of Medicine, Bucheon, Korea
– name: 5 Department of Internal Medicine, The Catholic University of Korea Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea
– name: 4 Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– name: 8 Department of Internal Medicine, The Catholic University of Korea St. Paul's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Young Seok
  surname: Kim
  fullname: Kim, Young Seok
  organization: Department of Internal Medicine, Soon Chun Hyang University Hospital Bucheon, Soon Chun Hyang University College of Medicine, Bucheon, Korea
– sequence: 2
  givenname: Eun Sun
  surname: Jung
  fullname: Jung, Eun Sun
  organization: Department of Pathology, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Wonhee
  surname: Hur
  fullname: Hur, Wonhee
  organization: The Catholic University of Korea Liver Research Center & WHO Collaborating Center of Viral Hepatitis, The Catholic University of Korea College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Si Hyun
  surname: Bae
  fullname: Bae, Si Hyun
  organization: Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Jong Young
  surname: Choi
  fullname: Choi, Jong Young
  organization: Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Myeong Jun
  surname: Song
  fullname: Song, Myeong Jun
  organization: Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– sequence: 7
  givenname: Chang Wook
  surname: Kim
  fullname: Kim, Chang Wook
  organization: Department of Internal Medicine, The Catholic University of Korea Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea
– sequence: 8
  givenname: Se Hyun
  surname: Jo
  fullname: Jo, Se Hyun
  organization: Department of Internal Medicine, The Catholic University of Korea Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– sequence: 9
  givenname: Chang Don
  surname: Lee
  fullname: Lee, Chang Don
  organization: Department of Internal Medicine, The Catholic University of Korea Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea
– sequence: 10
  givenname: Young Sok
  surname: Lee
  fullname: Lee, Young Sok
  organization: Department of Internal Medicine, The Catholic University of Korea Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Bucheon, Korea
– sequence: 11
  givenname: Sang Wook
  surname: Choi
  fullname: Choi, Sang Wook
  organization: Department of Internal Medicine, The Catholic University of Korea St. Paul's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
– sequence: 12
  givenname: Jin Mo
  surname: Yang
  fullname: Yang, Jin Mo
  organization: Department of Internal Medicine, The Catholic University of Korea St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea
– sequence: 13
  givenname: Jeong Won
  surname: Jang
  fullname: Jang, Jeong Won
  organization: Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Incheon, Korea
– sequence: 14
  givenname: Sang Gyune
  surname: Kim
  fullname: Kim, Sang Gyune
  organization: Department of Internal Medicine, Soon Chun Hyang University Hospital Bucheon, Soon Chun Hyang University College of Medicine, Bucheon, Korea
– sequence: 15
  givenname: Seung Won
  surname: Jung
  fullname: Jung, Seung Won
  organization: Department of Internal Medicine, Soon Chun Hyang University Hospital Seoul, Soon Chun Hyang University College of Medicine, Seoul, Korea
– sequence: 16
  givenname: Hee Kyung
  surname: Kim
  fullname: Kim, Hee Kyung
  organization: Department of Pathology, Soon Chun Hyang University Hospital Bucheon, Soon Chun Hyang University College of Medicine, Bucheon, Korea
– sequence: 17
  givenname: Hee Bok
  surname: Chae
  fullname: Chae, Hee Bok
  organization: Department of Internal Medicine, Chungbuk National University, College of Medicine, Cheongju, Korea
– sequence: 18
  givenname: Seung Kew
  surname: Yoon
  fullname: Yoon, Seung Kew
  organization: Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23837136$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001776492$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9Uk1vEzEUtFARbUN_ABdkiQuXBH_sru0LUlWVElGBhIrEzfJ6vVmnjh1sJyg_gP-NN6GF9IAvtp7nzcx7mnNw4oM3ALzCaEZpjd7p1TAjCNMZFjMywwQ9A2eEcDYlvP5-8vBmhJ-Ci5SWqByGSC3oC3BKKKcM0-YM_PocvPVblezWwHU0ndU5xARDD4uecjoMwVkNUzYqh8GsVbbZJmg9_BSiUR6OFeNzgj9tHuBgUw4uLKxWzu0KY9gaf0zVq5x30BXBCDubjErmJXjeK5fMxZ97Ar59uL67-ji9_XIzv7q8neqaNHmKlWA1RqiMVmOqW6F113ZNW9ZQC9bUplPcGEwJahjjnHe0EzVFPWe8J4QyOgFvD7w-9vJeWxmU3d-LIO-jvPx6N5eVIFUBT8D8AO2CWsp1tCsVd3v8vhDiQqqYrXZGdkWTo9ZQ3nYV5UwghVVFeIMqjLUeZd8fuNabdmU6XdYVlTsiPf7xdiiWtpIyhHlV_fVd9vljY1KWK5u0cU55EzZJYioEaaqqQQX65gl0GTaxrD9JiknDMGdsdPT6X0ePVh6CUQD4ANAxpBRN_wjBSI75kyV_csyfxEISWfJXetiTHm1zSUcYh7LuP52_AVYx4cs
CitedBy_id crossref_primary_10_1097_INF_0000000000000530
crossref_primary_10_3390_life10100230
crossref_primary_10_1007_s11901_017_0369_3
crossref_primary_10_3390_ijms17040562
crossref_primary_10_1016_j_atherosclerosis_2022_08_011
crossref_primary_10_1186_s12944_024_02396_3
crossref_primary_10_3389_fmed_2022_934989
crossref_primary_10_3390_ijms17040548
crossref_primary_10_1097_CM9_0000000000002603
crossref_primary_10_1186_1471_230X_14_39
crossref_primary_10_1371_journal_pone_0238717
crossref_primary_10_4166_kjg_2014_64_4_206
crossref_primary_10_1080_13813455_2020_1745851
crossref_primary_10_4103_1687_9945_337837
crossref_primary_10_5223_pghn_2014_17_4_248
crossref_primary_10_1002_jgh3_12716
crossref_primary_10_1155_2014_846923
crossref_primary_10_4166_kjg_2014_64_1_31
crossref_primary_10_1016_j_cgh_2017_08_024
crossref_primary_10_3350_cmh_2013_19_2_116
crossref_primary_10_1371_journal_pmed_1001680
crossref_primary_10_1002_hep_29466
crossref_primary_10_1016_j_jhep_2018_05_036
crossref_primary_10_1016_j_cca_2025_120147
crossref_primary_10_1111_eci_13939
crossref_primary_10_3390_biomedicines11030883
Cites_doi 10.1002/hep.24268
10.1016/j.jhep.2011.12.025
10.1002/hep.20701
10.1053/j.gastro.2005.03.084
10.1002/hep.21327
10.1111/j.1572-0241.1999.01377.x
10.1016/j.jhep.2010.05.018
10.1111/j.1365-2036.2006.02719.x
10.1055/s-0028-1091978
10.1136/gut.2004.060251
10.1016/j.yexcr.2007.04.024
10.1053/gast.2002.36572
10.1161/CIRCULATIONAHA.109.192644
10.1002/hep.21223
10.1053/jhep.2003.50161
10.2337/diabetes.50.8.1844
10.1007/s00535-010-0305-6
10.1002/hep.22429
10.1016/S0016-5085(03)00907-7
10.3109/07853890.2010.518623
10.1002/hep.23784
10.1016/j.cgh.2008.11.005
10.1016/j.metabol.2012.01.007
10.2337/diacare.20.7.1087
10.1016/j.jhep.2006.09.018
10.1111/j.1572-0241.2007.01322.x
10.1016/S0092-8674(04)00046-7
10.1053/j.gastro.2012.04.001
10.1111/j.1440-1746.2005.04086.x
10.3350/kjhep.2011.17.1.19
10.1002/hep.23527
10.1002/hep.22896
10.1111/j.1365-2796.1994.tb00802.x
10.1002/hep.23050
10.1136/gut.2009.205088
10.1309/WWNE-KW2C-4KTW-PTJ5
10.1053/j.gastro.2005.04.014
10.1016/S0016-5085(99)70506-8
10.1002/hep.24376
10.1002/hep.24706
10.1002/hep.23433
10.1002/hep.21768
10.1111/j.1478-3231.2011.02488.x
10.1053/j.gastro.2010.02.058
10.1097/MCG.0b013e3181bdefe2
10.1002/hep.20283
10.1002/hep.23594
ContentType Journal Article
Copyright 2013. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2013 by The Korean Association for the Study of the Liver 2013
Copyright_xml – notice: 2013. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2013 by The Korean Association for the Study of the Liver 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
ACYCR
DOI 10.3350/cmh.2013.19.2.120
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central (subscription)
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: ProQuest Health & Medical Collection (NC LIVE)
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2287-285X
EndPage 130
ExternalDocumentID oai_kci_go_kr_ARTI_492422
oai_doaj_org_article_dee180be38bd438790a1a42860411cc7
PMC3701844
23837136
10_3350_cmh_2013_19_2_120
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Republic of Korea
GeographicLocations_xml – name: Republic of Korea
GroupedDBID 5-W
7X7
8FI
8FJ
8JR
8XY
9ZL
AAYXX
ABUWG
ACYCR
ADBBV
ADRAZ
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
EBD
EF.
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IPNFZ
KQ8
M48
PGMZT
PHGZM
PHGZT
PIMPY
RIG
RNS
RPM
SV3
UKHRP
CGR
CUY
CVF
ECM
EIF
M~E
NPM
OK1
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c526t-1a975100228513cb9ccdbd6b20159765eda8ee1320677888d3d9530f878f22373
IEDL.DBID M48
ISSN 2287-2728
2287-285X
IngestDate Tue Nov 21 21:18:27 EST 2023
Wed Aug 27 01:21:05 EDT 2025
Thu Aug 21 13:51:58 EDT 2025
Thu Jul 10 19:16:11 EDT 2025
Mon Jun 30 14:38:03 EDT 2025
Thu Jan 02 22:17:22 EST 2025
Tue Jul 01 04:27:40 EDT 2025
Thu Apr 24 23:01:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Cytokeratin-18
Nonalcoholic fatty liver disease
Ferritin
Language English
License http://creativecommons.org/licenses/by-nc/3.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c526t-1a975100228513cb9ccdbd6b20159765eda8ee1320677888d3d9530f878f22373
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors equally contributed to this work.
G704-001530.2013.19.2.006
http://www.e-cmh.org/
OpenAccessLink https://www.proquest.com/docview/3126718777?pq-origsite=%requestingapplication%
PMID 23837136
PQID 3126718777
PQPubID 7084873
PageCount 11
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_492422
doaj_primary_oai_doaj_org_article_dee180be38bd438790a1a42860411cc7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3701844
proquest_miscellaneous_1399264460
proquest_journals_3126718777
pubmed_primary_23837136
crossref_primary_10_3350_cmh_2013_19_2_120
crossref_citationtrail_10_3350_cmh_2013_19_2_120
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-06-01
PublicationDateYYYYMMDD 2013-06-01
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
– name: Seoul
PublicationTitle Clinical and molecular hepatology
PublicationTitleAlternate Clin Mol Hepatol
PublicationYear 2013
Publisher Korean Association for the Study of the Liver
The Korean Association for the Study of the Liver
대한간학회
Publisher_xml – name: Korean Association for the Study of the Liver
– name: The Korean Association for the Study of the Liver
– name: 대한간학회
References Brunt (10.3350/cmh.2013.19.2.120_ref7) 1999; 94
Zatloukal (10.3350/cmh.2013.19.2.120_ref38) 2007; 313
Shen (10.3350/cmh.2013.19.2.120_ref21) 2012; 56
Adams (10.3350/cmh.2013.19.2.120_ref10) 2005; 129
Shimada (10.3350/cmh.2013.19.2.120_ref26) 2007; 102
Kleiner (10.3350/cmh.2013.19.2.120_ref16) 2005; 41
Starley (10.3350/cmh.2013.19.2.120_ref12) 2010; 51
Ratziu (10.3350/cmh.2013.19.2.120_ref15) 2005; 128
Marchesini (10.3350/cmh.2013.19.2.120_ref4) 2003; 37
Matteoni (10.3350/cmh.2013.19.2.120_ref9) 1999; 116
Kowdley (10.3350/cmh.2013.19.2.120_ref18) 2012; 55
Ekstedt (10.3350/cmh.2013.19.2.120_ref8) 2006; 44
Bonnefont-Rousselot (10.3350/cmh.2013.19.2.120_ref25) 2006; 23
Milner (10.3350/cmh.2013.19.2.120_ref20) 2009; 49
Park (10.3350/cmh.2013.19.2.120_ref2) 2011; 17
Li (10.3350/cmh.2013.19.2.120_ref23) 2010; 53
Zelber-Sagi (10.3350/cmh.2013.19.2.120_ref46) 2007; 46
Sumida (10.3350/cmh.2013.19.2.120_ref27) 2011; 46
Danial (10.3350/cmh.2013.19.2.120_ref29) 2004; 116
Feldstein (10.3350/cmh.2013.19.2.120_ref39) 2004; 40
Chalasani (10.3350/cmh.2013.19.2.120_ref42) 2012; 142
Feldstein (10.3350/cmh.2013.19.2.120_ref19) 2009; 50
Park (10.3350/cmh.2013.19.2.120_ref3) 2006; 21
Neuschwander-Tetri (10.3350/cmh.2013.19.2.120_ref37) 2010; 52
Musso (10.3350/cmh.2013.19.2.120_ref40) 2011; 43
Fontana (10.3350/cmh.2013.19.2.120_ref14) 2010; 138
Younossi (10.3350/cmh.2013.19.2.120_ref33) 2011; 53
Lazo (10.3350/cmh.2013.19.2.120_ref1) 2008; 28
Wong (10.3350/cmh.2013.19.2.120_ref11) 2010; 59
Feldstein (10.3350/cmh.2013.19.2.120_ref28) 2003; 125
Sanyal (10.3350/cmh.2013.19.2.120_ref6) 2002; 123
Haffner (10.3350/cmh.2013.19.2.120_ref31) 1997; 20
Bell (10.3350/cmh.2013.19.2.120_ref43) 1994; 236
Marchesini (10.3350/cmh.2013.19.2.120_ref5) 2001; 50
Turlin (10.3350/cmh.2013.19.2.120_ref44) 2001; 116
Fracanzani (10.3350/cmh.2013.19.2.120_ref47) 2008; 48
Rafiq (10.3350/cmh.2013.19.2.120_ref34) 2009; 7
Sanyal (10.3350/cmh.2013.19.2.120_ref35) 2011; 54
Wieckowska (10.3350/cmh.2013.19.2.120_ref41) 2007; 46
Manousou (10.3350/cmh.2013.19.2.120_ref45) 2011; 31
Assy (10.3350/cmh.2013.19.2.120_ref24) 2005; 54
Ascha (10.3350/cmh.2013.19.2.120_ref13) 2010; 51
Tsutsui (10.3350/cmh.2013.19.2.120_ref36) 2010; 44
Alberti (10.3350/cmh.2013.19.2.120_ref32) 2009; 120
Kim (10.3350/cmh.2013.19.2.120_ref17) 2012; 61
Wieckowska (10.3350/cmh.2013.19.2.120_ref30) 2006; 44
Li (10.3350/cmh.2013.19.2.120_ref22) 2010; 51
17531973 - Exp Cell Res. 2007 Jun 10;313(10):2033-49
21457446 - Liver Int. 2011 May;31(5):730-9
17006923 - Hepatology. 2006 Oct;44(4):865-73
21520200 - Hepatology. 2011 Jul;54(1):344-53
19049831 - Clin Gastroenterol Hepatol. 2009 Feb;7(2):234-8
19805654 - Circulation. 2009 Oct 20;120(16):1640-5
22656328 - Gastroenterology. 2012 Jun;142(7):1592-609
18752331 - Hepatology. 2008 Sep;48(3):792-8
15239102 - Hepatology. 2004 Jul;40(1):185-94
20581244 - Gut. 2010 Jul;59(7):969-74
19585618 - Hepatology. 2009 Oct;50(4):1072-8
20675007 - J Hepatol. 2010 Nov;53(5):934-40
9203442 - Diabetes Care. 1997 Jul;20(7):1087-92
15940625 - Gastroenterology. 2005 Jun;128(7):1898-906
16799979 - Hepatology. 2006 Jul;44(1):27-33
16012941 - Gastroenterology. 2005 Jul;129(1):113-21
20842510 - J Gastroenterol. 2011 Feb;46(2):257-68
22314419 - J Hepatol. 2012 Jun;56(6):1363-70
10484010 - Am J Gastroenterol. 1999 Sep;94(9):2467-74
20648476 - Hepatology. 2010 Sep;52(3):913-24
15915461 - Hepatology. 2005 Jun;41(6):1313-21
10348825 - Gastroenterology. 1999 Jun;116(6):1413-9
16706825 - J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):138-43
19475694 - Hepatology. 2009 Jun;49(6):1926-34
17511754 - Am J Gastroenterol. 2007 Sep;102(9):1931-8
21953442 - Hepatology. 2012 Jan;55(1):77-85
15831928 - Gut. 2005 May;54(5):729
18956290 - Semin Liver Dis. 2008 Nov;28(4):339-50
11473047 - Diabetes. 2001 Aug;50(8):1844-50
8077889 - J Intern Med. 1994 Sep;236(3):315-22
17150278 - J Hepatol. 2007 Apr;46(4):700-7
23837135 - Clin Mol Hepatol. 2013 Jun;19(2):116-9
20041411 - Hepatology. 2010 May;51(5):1865-6
20209604 - Hepatology. 2010 Jun;51(6):1972-8
20432259 - Hepatology. 2010 May;51(5):1820-32
12891546 - Gastroenterology. 2003 Aug;125(2):437-43
21494074 - Korean J Hepatol. 2011 Mar;17(1):19-26
12404245 - Gastroenterology. 2002 Nov;123(5):1705-25
17661414 - Hepatology. 2007 Aug;46(2):582-9
20211180 - Gastroenterology. 2010 Jun;138(7):2321-31, 2331.e1-2
12668987 - Hepatology. 2003 Apr;37(4):917-23
20104187 - J Clin Gastroenterol. 2010 Jul;44(6):440-7
14744432 - Cell. 2004 Jan 23;116(2):205-19
21039302 - Ann Med. 2011 Dec;43(8):617-49
21360720 - Hepatology. 2011 Jun;53(6):1874-82
16393285 - Aliment Pharmacol Ther. 2006 Jan 1;23(1):91-8
11488074 - Am J Clin Pathol. 2001 Aug;116(2):263-70
22386931 - Metabolism. 2012 Aug;61(8):1182-8
References_xml – volume: 53
  start-page: 1874
  year: 2011
  ident: 10.3350/cmh.2013.19.2.120_ref33
  publication-title: Hepatology
  doi: 10.1002/hep.24268
– volume: 56
  start-page: 1363
  year: 2012
  ident: 10.3350/cmh.2013.19.2.120_ref21
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.12.025
– volume: 41
  start-page: 1313
  year: 2005
  ident: 10.3350/cmh.2013.19.2.120_ref16
  publication-title: Hepatology
  doi: 10.1002/hep.20701
– volume: 128
  start-page: 1898
  year: 2005
  ident: 10.3350/cmh.2013.19.2.120_ref15
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.03.084
– volume: 44
  start-page: 865
  year: 2006
  ident: 10.3350/cmh.2013.19.2.120_ref8
  publication-title: Hepatology
  doi: 10.1002/hep.21327
– volume: 94
  start-page: 2467
  year: 1999
  ident: 10.3350/cmh.2013.19.2.120_ref7
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01377.x
– volume: 53
  start-page: 934
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref23
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.05.018
– volume: 23
  start-page: 91
  year: 2006
  ident: 10.3350/cmh.2013.19.2.120_ref25
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2006.02719.x
– volume: 28
  start-page: 339
  year: 2008
  ident: 10.3350/cmh.2013.19.2.120_ref1
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0028-1091978
– volume: 54
  start-page: 729
  year: 2005
  ident: 10.3350/cmh.2013.19.2.120_ref24
  publication-title: Gut
  doi: 10.1136/gut.2004.060251
– volume: 313
  start-page: 2033
  year: 2007
  ident: 10.3350/cmh.2013.19.2.120_ref38
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2007.04.024
– volume: 123
  start-page: 1705
  year: 2002
  ident: 10.3350/cmh.2013.19.2.120_ref6
  publication-title: Gastroenterology
  doi: 10.1053/gast.2002.36572
– volume: 120
  start-page: 1640
  year: 2009
  ident: 10.3350/cmh.2013.19.2.120_ref32
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.192644
– volume: 44
  start-page: 27
  year: 2006
  ident: 10.3350/cmh.2013.19.2.120_ref30
  publication-title: Hepatology
  doi: 10.1002/hep.21223
– volume: 37
  start-page: 917
  year: 2003
  ident: 10.3350/cmh.2013.19.2.120_ref4
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50161
– volume: 50
  start-page: 1844
  year: 2001
  ident: 10.3350/cmh.2013.19.2.120_ref5
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.8.1844
– volume: 46
  start-page: 257
  year: 2011
  ident: 10.3350/cmh.2013.19.2.120_ref27
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-010-0305-6
– volume: 48
  start-page: 792
  year: 2008
  ident: 10.3350/cmh.2013.19.2.120_ref47
  publication-title: Hepatology
  doi: 10.1002/hep.22429
– volume: 125
  start-page: 437
  year: 2003
  ident: 10.3350/cmh.2013.19.2.120_ref28
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(03)00907-7
– volume: 43
  start-page: 617
  year: 2011
  ident: 10.3350/cmh.2013.19.2.120_ref40
  publication-title: Ann Med
  doi: 10.3109/07853890.2010.518623
– volume: 52
  start-page: 913
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref37
  publication-title: Hepatology
  doi: 10.1002/hep.23784
– volume: 7
  start-page: 234
  year: 2009
  ident: 10.3350/cmh.2013.19.2.120_ref34
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2008.11.005
– volume: 61
  start-page: 1182
  year: 2012
  ident: 10.3350/cmh.2013.19.2.120_ref17
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2012.01.007
– volume: 20
  start-page: 1087
  year: 1997
  ident: 10.3350/cmh.2013.19.2.120_ref31
  publication-title: Diabetes Care
  doi: 10.2337/diacare.20.7.1087
– volume: 46
  start-page: 700
  year: 2007
  ident: 10.3350/cmh.2013.19.2.120_ref46
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2006.09.018
– volume: 102
  start-page: 1931
  year: 2007
  ident: 10.3350/cmh.2013.19.2.120_ref26
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2007.01322.x
– volume: 116
  start-page: 205
  year: 2004
  ident: 10.3350/cmh.2013.19.2.120_ref29
  publication-title: Cell
  doi: 10.1016/S0092-8674(04)00046-7
– volume: 142
  start-page: 1592
  year: 2012
  ident: 10.3350/cmh.2013.19.2.120_ref42
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2012.04.001
– volume: 21
  start-page: 138
  year: 2006
  ident: 10.3350/cmh.2013.19.2.120_ref3
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2005.04086.x
– volume: 17
  start-page: 19
  year: 2011
  ident: 10.3350/cmh.2013.19.2.120_ref2
  publication-title: Korean J Hepatol
  doi: 10.3350/kjhep.2011.17.1.19
– volume: 51
  start-page: 1972
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref13
  publication-title: Hepatology
  doi: 10.1002/hep.23527
– volume: 49
  start-page: 1926
  year: 2009
  ident: 10.3350/cmh.2013.19.2.120_ref20
  publication-title: Hepatology
  doi: 10.1002/hep.22896
– volume: 236
  start-page: 315
  year: 1994
  ident: 10.3350/cmh.2013.19.2.120_ref43
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.1994.tb00802.x
– volume: 50
  start-page: 1072
  year: 2009
  ident: 10.3350/cmh.2013.19.2.120_ref19
  publication-title: Hepatology
  doi: 10.1002/hep.23050
– volume: 59
  start-page: 969
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref11
  publication-title: Gut
  doi: 10.1136/gut.2009.205088
– volume: 116
  start-page: 263
  year: 2001
  ident: 10.3350/cmh.2013.19.2.120_ref44
  publication-title: Am J Clin Pathol
  doi: 10.1309/WWNE-KW2C-4KTW-PTJ5
– volume: 129
  start-page: 113
  year: 2005
  ident: 10.3350/cmh.2013.19.2.120_ref10
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.04.014
– volume: 116
  start-page: 1413
  year: 1999
  ident: 10.3350/cmh.2013.19.2.120_ref9
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
– volume: 54
  start-page: 344
  year: 2011
  ident: 10.3350/cmh.2013.19.2.120_ref35
  publication-title: Hepatology
  doi: 10.1002/hep.24376
– volume: 55
  start-page: 77
  year: 2012
  ident: 10.3350/cmh.2013.19.2.120_ref18
  publication-title: Hepatology
  doi: 10.1002/hep.24706
– volume: 51
  start-page: 1865
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref22
  publication-title: Hepatology
  doi: 10.1002/hep.23433
– volume: 46
  start-page: 582
  year: 2007
  ident: 10.3350/cmh.2013.19.2.120_ref41
  publication-title: Hepatology
  doi: 10.1002/hep.21768
– volume: 31
  start-page: 730
  year: 2011
  ident: 10.3350/cmh.2013.19.2.120_ref45
  publication-title: Liver Int
  doi: 10.1111/j.1478-3231.2011.02488.x
– volume: 138
  start-page: 2321
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref14
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.02.058
– volume: 44
  start-page: 440
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref36
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e3181bdefe2
– volume: 40
  start-page: 185
  year: 2004
  ident: 10.3350/cmh.2013.19.2.120_ref39
  publication-title: Hepatology
  doi: 10.1002/hep.20283
– volume: 51
  start-page: 1820
  year: 2010
  ident: 10.3350/cmh.2013.19.2.120_ref12
  publication-title: Hepatology
  doi: 10.1002/hep.23594
– reference: 15239102 - Hepatology. 2004 Jul;40(1):185-94
– reference: 15940625 - Gastroenterology. 2005 Jun;128(7):1898-906
– reference: 19585618 - Hepatology. 2009 Oct;50(4):1072-8
– reference: 18956290 - Semin Liver Dis. 2008 Nov;28(4):339-50
– reference: 20211180 - Gastroenterology. 2010 Jun;138(7):2321-31, 2331.e1-2
– reference: 15831928 - Gut. 2005 May;54(5):729
– reference: 11488074 - Am J Clin Pathol. 2001 Aug;116(2):263-70
– reference: 12668987 - Hepatology. 2003 Apr;37(4):917-23
– reference: 15915461 - Hepatology. 2005 Jun;41(6):1313-21
– reference: 19805654 - Circulation. 2009 Oct 20;120(16):1640-5
– reference: 21039302 - Ann Med. 2011 Dec;43(8):617-49
– reference: 16393285 - Aliment Pharmacol Ther. 2006 Jan 1;23(1):91-8
– reference: 19475694 - Hepatology. 2009 Jun;49(6):1926-34
– reference: 22386931 - Metabolism. 2012 Aug;61(8):1182-8
– reference: 10348825 - Gastroenterology. 1999 Jun;116(6):1413-9
– reference: 20675007 - J Hepatol. 2010 Nov;53(5):934-40
– reference: 20432259 - Hepatology. 2010 May;51(5):1820-32
– reference: 14744432 - Cell. 2004 Jan 23;116(2):205-19
– reference: 19049831 - Clin Gastroenterol Hepatol. 2009 Feb;7(2):234-8
– reference: 20104187 - J Clin Gastroenterol. 2010 Jul;44(6):440-7
– reference: 10484010 - Am J Gastroenterol. 1999 Sep;94(9):2467-74
– reference: 18752331 - Hepatology. 2008 Sep;48(3):792-8
– reference: 11473047 - Diabetes. 2001 Aug;50(8):1844-50
– reference: 20648476 - Hepatology. 2010 Sep;52(3):913-24
– reference: 23837135 - Clin Mol Hepatol. 2013 Jun;19(2):116-9
– reference: 21494074 - Korean J Hepatol. 2011 Mar;17(1):19-26
– reference: 12891546 - Gastroenterology. 2003 Aug;125(2):437-43
– reference: 16799979 - Hepatology. 2006 Jul;44(1):27-33
– reference: 20041411 - Hepatology. 2010 May;51(5):1865-6
– reference: 9203442 - Diabetes Care. 1997 Jul;20(7):1087-92
– reference: 22314419 - J Hepatol. 2012 Jun;56(6):1363-70
– reference: 21457446 - Liver Int. 2011 May;31(5):730-9
– reference: 20209604 - Hepatology. 2010 Jun;51(6):1972-8
– reference: 20581244 - Gut. 2010 Jul;59(7):969-74
– reference: 21360720 - Hepatology. 2011 Jun;53(6):1874-82
– reference: 22656328 - Gastroenterology. 2012 Jun;142(7):1592-609
– reference: 17006923 - Hepatology. 2006 Oct;44(4):865-73
– reference: 17150278 - J Hepatol. 2007 Apr;46(4):700-7
– reference: 12404245 - Gastroenterology. 2002 Nov;123(5):1705-25
– reference: 8077889 - J Intern Med. 1994 Sep;236(3):315-22
– reference: 17511754 - Am J Gastroenterol. 2007 Sep;102(9):1931-8
– reference: 21953442 - Hepatology. 2012 Jan;55(1):77-85
– reference: 16706825 - J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):138-43
– reference: 21520200 - Hepatology. 2011 Jul;54(1):344-53
– reference: 17661414 - Hepatology. 2007 Aug;46(2):582-9
– reference: 17531973 - Exp Cell Res. 2007 Jun 10;313(10):2033-49
– reference: 16012941 - Gastroenterology. 2005 Jul;129(1):113-21
– reference: 20842510 - J Gastroenterol. 2011 Feb;46(2):257-68
SSID ssj0000702593
Score 2.0488362
Snippet The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from...
Background/AimsThe aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic...
Background/Aims: The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 120
SubjectTerms Adult
Aged
Aged, 80 and over
Alanine Transaminase - blood
Apoptosis
Asian Continental Ancestry Group
Aspartate Aminotransferases - blood
Biomarkers
Biomarkers - blood
Biopsy
Blood pressure
Body mass index
Cholesterol
Correlation analysis
Cytokeratin-18
Data analysis
Diabetes
Fatty Liver - classification
Fatty Liver - metabolism
Fatty Liver - pathology
Female
Ferritin
Ferritins - blood
Fibrosis - complications
Gastrointestinal surgery
Glucose
High density lipoprotein
Hospitals
Humans
Hypertension
Inflammation
Insulin resistance
Keratin-18 - analysis
Laboratories
Liver diseases
Male
Metabolic syndrome
Middle Aged
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease
Obesity
Original
Predictive Value of Tests
Prospective Studies
Republic of Korea
Severity of Illness Index
Young Adult
내과학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICNxQsrWj8R2joCoCqg9Uak3y6_QqNuk2k2R-gP438w46WoXIbhwipSHY_ubeGY8k28IeatcbLmvQgn41mXVpFh6mVTpHZKD-BZwwX-Hj0_U0Wn15aw-2yr1hTlhEz3wNHEHMSVumE_S-FhJoxvmuAObWbGK8xDyf-Sg87acqbwGa9DlmXFXgEtQCi3MFNKUsmYH4RLDEFwueLMQC461vreUUubuB1XTr9o_mZ2_Z09uqaPDB-T-bEfS91P_H5I7qX9E7h7PkfLH5OcJ7rP-cJidTq9WeB7r6tChpT0a37kwbhcogjwO5wkTq8duTbuefh3AkOzpzLi6prhVSzMv8bxOLm8o7kSkfrep1o3jDV1ioged4z5PyOnhp28fj8q55EIZaqHGkrtG1zyT4tRcBt-EEH1UHmYLPA9Vp-gMACJFJp4zJsrY1JK1RpsWDA0tn5I9eHV6TiiYYi0PrcJQZlXVvokMmmJRGpd0HWVB2O2c2zDzkWNZjKUFvwRhsgCTRZgsb6ywAFNB3m0euZrIOP528wcEcnMj8mjnEyBddpYu-y_pKsgbEAN7Ebr8PB6_D_ZiZcHb-GwrcF6FKMj-rZDYeQFYW8mFArWvNTaxuQyfLsZjXJ-G67XlSAoM9qiCvj6bZGrTW4E7B1yqgugdadsZzu6VvjvP9OBSM3Dbqxf_Y_wvyT0x1f8oGd8ne-PqOr0CK2z0r_MH9wvZGi9O
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection (NC LIVE)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2gICNxQso2thM7OSFAVAXUnqi0N8uvtFGXZNmkSP0B_G9mEm_oItTTSnl4nXzj8bzyDSFvpfE1s7lLAd8izavgUyuCTK1BchBbAy747fDxiTw6zb8ui2UMuPWxrHKrE0dF7TuHMfIDwbgEPaqUer_-mWLXKMyuxhYat8kdpC5DqVZLNcdYQJz5xLvLwTFIueLllNgUosgO3A9MRjCxYNWCLxh2_L62NY0M_rDhtJv6f8bnvzWU1zalwwfkfrQm6YcJ_ofkVmgfkbvHMV_-mPw-wWjrL4M16nS9wePYXYd2NW3RBB_b4zaOItRDdx6wvHpoetq09FsH5mRLI-9qTzFgS0d24qgtV1cU4xGh3R2qNsNwRVdY7kFj9ucJOT38_P3TURobL6Su4HJImalUwUZqnIIJZyvnvPXSwtsC_0MWwZsyBPz4GunnytILXxUiq0tV1mBuKPGU7MFfh-eEgkFWM1dLTGjmeWErn8FQmRelCarwIiHZ9p1rF1nJsTnGSoN3gjBpgEkjTJpVmmuAKSHv5lvWEyXHTRd_RCDnC5FNezzQbc50XJzaw8OUmQ2itD4Xpaoywwz4ZTLLGXNOJeQNiIG-cM14P_6edfpio8Hn-KJzcGE5T8j-Vkh0VAO9_iu0MMR8GhYwZmVMG7rLXjOkBgarVMJcn00yNc-WY_yACZkQtSNtO4-ze6ZtzkeScKEycN7zFzdP6yW5x6f-HmnG9snesLkMr8DKGuzrcSn9Ac2DJzw
  priority: 102
  providerName: ProQuest
Title Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
URI https://www.ncbi.nlm.nih.gov/pubmed/23837136
https://www.proquest.com/docview/3126718777
https://www.proquest.com/docview/1399264460
https://pubmed.ncbi.nlm.nih.gov/PMC3701844
https://doaj.org/article/dee180be38bd438790a1a42860411cc7
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001776492
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Clinical and Molecular Hepatology, 2013, 19(2), , pp.120-130
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbGJiFeEPcVRmUknpBSYju2kweEGNo0QK0QYlLfrPiSrVpJRpoh-gP435zjphVFFeIpUi5O4nMcf985zncIealKXzGbuQTsK5OsCD6xIqjEligOYiuwC_47PJ6os_Ps41RO98i6vFXfgYud1A7rSZ2389HP78u3MODfIOMUMn3tvmFWgYkRK0Z8xDgw-AOYmDQWNBj3aD9-mDVM8FGGlwNPSHgup6s85-5WtmaqKOgP80_dVruw6N9LKv-Yo07vkbs9uKTvVt5wn-yF-gG5Pe7T5w_JrwkGX3-UuGSdXre4H4vt0KaiNSLyWC135ihavmsuA6627mYLOqvppwbQZU17GdYFxfgtjWLF_cdzvqQYngj1dlNV2XVLOsfVH7RPBj0i56cnX9-fJX0dhsRJrrqElYWWLCrlSCacLZzz1isLvQV0RMngyzwE_Bcb1ejy3AtfSJFWuc4rQB9aPCb7cOtwSCjgs4q5SmF-M8ukLXwKTaVe5GXQ0osBSdd9blwvUo61MuYGyAqayYCZDJrJsMJwA2YakFebS65XCh3_OvkYDbk5EcW1446mvTD9WDUeXiZPbRC59ZnIdZGWrASaptKMMef0gLwANzBXbhavx-1FY65aAxTkg8mA0XI-IEdrJzFrpzaCcQVYQGtsYnMYxjMmaco6NDcLw1ApGECqgmd9svKpzdNyDCcwoQZEb3nb1utsH6lnl1EzXOgUuHz29D_u-4zc4auaH0nKjsh-196E54C8Ojskt_RUD8nB8cnk85dhjF8M4xj7DTgiMBQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxJtAgUWCC5JT767tXR8Q4lUlpMmplXJbvA-3VoMdEheUH8Df4TcyYzuhQai3niz5sV57Zue93xDyKslczkxkA6BvHESpd4ERPglMhuAgJge64N7h8SQZHEdfpvF0h_xe74XBssq1TGwEtassxsj3BeMJyFEp5bv59wC7RmF2dd1Co2WLkV_9BJdt-Xb4Cej7mvODz0cfB0HXVSCwMU_qgGWpjFmD-xIzYU1qrTMuMaAJwbhOYu8y5T3uLEZsNaWccGkswlxJlYMulQLGvUaug-IN0dmTU7mJ6cDy4S3OLwwuAy65ahOpQsThvv2GyQ8m-izt8z7DDuMXVGHTMQAUXLnI_2fs_luzeUEJHtwhtzvrlb5v2e0u2fHlPXJj3OXn75NfE4zu_siwJp7OF3geu_nQKqclmvxNO97CUmStujr1WM5dF0talHRUgfla0g7ndUkxQEwbNOROOs9WFOMfvtweKs_qekVnWF5Cu2zTA3J8JSR5SHbh1f4xoWAA5szmCSZQoyg2qQthqNAJlXkZO9Ej4fqfa9uhoGMzjpkGbwjJpIFMGsmkWaq5BjL1yJvNI_MWAuSymz8gITc3Inp3c6JanOhOGGgHH6NC44UyLhJKpmHGMvADkzBizFrZIy-BDfSZLZrn8XhS6bOFBh9nqCNwmTnvkb01k-hO7Cz130UCQ2wug8DALFBW-up8qRlCEYMVnMBcH7U8tZktx3gFE0mPyC1u2_qc7StlcdqAkgsZMhVFTy6f1gtyc3A0PtSHw8noKbnF294iQcj2yG69OPfPwMKrzfNmWVHy9arX8R9bCGG1
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Noninvasive+predictors+of+nonalcoholic+steatohepatitis+in+Korean+patients+with+histologically+proven+nonalcoholic+fatty+liver+disease&rft.jtitle=Clinical+and+molecular+hepatology&rft.au=Kim%2C+Young+Seok&rft.au=Jung%2C+Eun+Sun&rft.au=Hur%2C+Wonhee&rft.au=Bae%2C+Si+Hyun&rft.date=2013-06-01&rft.issn=2287-285X&rft.eissn=2287-285X&rft.volume=19&rft.issue=2&rft.spage=120&rft_id=info:doi/10.3350%2Fcmh.2013.19.2.120&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-2728&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-2728&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-2728&client=summon